137 related articles for article (PubMed ID: 17533395)
1. The influence of alpha1-antagonist on the expression pattern of TNF receptor family in primary culture of prostate epithelial cells from BPH patients.
Drewa T; Wolski Z; Misterek B; Debski R; Styczynski J
Prostate Cancer Prostatic Dis; 2008; 11(1):88-93. PubMed ID: 17533395
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
Tahmatzopoulos A; Kyprianou N
Prostate; 2004 Apr; 59(1):91-100. PubMed ID: 14991869
[TBL] [Abstract][Full Text] [Related]
4. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
Benning CM; Kyprianou N
Cancer Res; 2002 Jan; 62(2):597-602. PubMed ID: 11809715
[TBL] [Abstract][Full Text] [Related]
5. Molecular targets of doxazosin in human prostatic stromal cells.
Zhao H; Lai F; Nonn L; Brooks JD; Peehl DM
Prostate; 2005 Mar; 62(4):400-10. PubMed ID: 15378519
[TBL] [Abstract][Full Text] [Related]
6. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
Kyprianou N; Benning CM
Cancer Res; 2000 Aug; 60(16):4550-5. PubMed ID: 10969806
[TBL] [Abstract][Full Text] [Related]
7. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
Kyprianou N
J Urol; 2003 Apr; 169(4):1520-5. PubMed ID: 12629407
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic activity of doxazosin on prostate stroma in vitro is mediated through an autocrine expression of TGF-beta1.
Ilio KY; Park II; Pins MR; Kozlowski JM; Lee C
Prostate; 2001 Aug; 48(3):131-5. PubMed ID: 11494328
[TBL] [Abstract][Full Text] [Related]
9. Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway.
Garrison JB; Kyprianou N
Cancer Res; 2006 Jan; 66(1):464-72. PubMed ID: 16397262
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibitory effect of doxazosin on prostate and bladder cancer cells. Is the serotonin receptor pathway involved?
Siddiqui EJ; Shabbir M; Thompson CS; Mumtaz FH; Mikhailidis DP
Anticancer Res; 2005; 25(6B):4281-6. PubMed ID: 16309229
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic regression of prostatic tissue induced by short-term doxazosin treatment in benign prostatic hyperplasia.
Türkeri LN; Ozyürek M; Ersev D; Akdaş A
Arch Esp Urol; 2001 Mar; 54(2):191-6. PubMed ID: 11341128
[TBL] [Abstract][Full Text] [Related]
12. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
[TBL] [Abstract][Full Text] [Related]
13. Benign prostatic hyperplasia cell line viability and modulation of jm-27 by doxazosin and Ibuprofen.
Minnery CH; Getzenberg RH
J Urol; 2005 Jul; 174(1):375-9. PubMed ID: 15947693
[TBL] [Abstract][Full Text] [Related]
14. Involvement of transcription factor activator protein-2alpha in doxazosin-induced HeLa cell apoptosis.
Gan L; Zhu DX; Yang LP; Liu RS; Yan F; Zhang J
Acta Pharmacol Sin; 2008 Apr; 29(4):465-72. PubMed ID: 18358093
[TBL] [Abstract][Full Text] [Related]
15. Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia.
Kyprianou N; Litvak JP; Borkowski A; Alexander R; Jacobs SC
J Urol; 1998 Jun; 159(6):1810-5. PubMed ID: 9598465
[TBL] [Abstract][Full Text] [Related]
16. TNF receptor deficiency reveals a translational control mechanism for adriamycin-induced Fas expression in cardiac tissues.
Lien YC; Daosukho C; St Clair DK
Cytokine; 2006 Feb; 33(4):226-30. PubMed ID: 16616515
[TBL] [Abstract][Full Text] [Related]
17. Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells.
Qi CJ; Zheng L; Zhou X; Tao Y; Ge Y; Zhuang YM; Xu Y; Yu G; Zhang XG
Immunol Lett; 2004 May; 93(2-3):151-8. PubMed ID: 15158611
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
[TBL] [Abstract][Full Text] [Related]
20. Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component.
Anglin IE; Glassman DT; Kyprianou N
Prostate Cancer Prostatic Dis; 2002; 5(2):88-95. PubMed ID: 12496995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
